Australian Government Department of Health and Ageing Immunisation HandbookAustralian Government Department of Health and Ageing crest. Link to the Immunise Australia Program homepage.

Quick Guides

Adverse Events Following Immunisation

Commonly observed adverse events following immunisation with vaccines used in the National Immunisation Program (NIP) schedule and what to do about them

The following information can be photocopied and given as post-vaccination advice.

All the common adverse events following immunisation are usually mild and transient and treatment is not usually required. If the adverse event following immunisation is severe or persistent, or if you are worried about yourself or your child’s condition, see your doctor or immunisation clinic nurse as soon as possible or go to a hospital. Adverse events may be reported via ADRAC, State and Territory Health Authorities or via immunisation service providers.

Diphtheria-tetanus-pertussis (acellular) DTPa-containing vaccines and dTpa (adolescent/adult) vaccines

Haemophilus influenzae type b vaccine (Hib)

Hepatitis A vaccine (HepA) (Indigenous children NT, QLD, SA, WA)

Hepatitis B vaccine (HepB)
  • Localised pain, redness and swelling at injection site
  • Occasionally injection site nodule, may last many weeks (no treatment needed)
  • Low-grade temperature (fever)
  • In children the following may also occur:
  • Irritable, crying, unsettled and generally unhappy
  • Drowsiness or tiredness
  • Localised pain, redness and swelling at injection site
  • Occasionally injection site nodule, may last many weeks (no treatment needed)
  • Low-grade temperature (fever)
  • Localised pain, redness and swelling at injection site
  • Low-grade temperature (fever)
  • Localised pain, redness and swelling at injection site
  • Occasionally injection site nodule, may last many weeks (no treatment needed)
  • Low-grade temperature (fever)

Human papillomavirus vaccine (HPV)

Influenza vaccine

Measles-mumps-rubella vaccine (MMR)

Meningococcal C conjugate vaccine (MenCCV)

  • Localised pain, redness and swelling at injection site
  • Low-grade temperature (fever)
  • Mild headache
  • Mild nausea
  • Drowsiness or tiredness
  • Muscle aches
  • Localised pain, redness and swelling at injection site
  • Occasionally injection site nodule, may last many weeks (no treatment needed)
  • Low-grade temperature (fever)
  • Occasionally injection site nodule, may last many weeks (no treatment needed)

Seen 7–10 days after vaccination:

  • Temperature (fever, can be >39.4 0 C) lasting 2–3 days, faint red rash (not infectious), head cold and/or runny nose, cough and/or puffy eyes
  • Drowsiness or tiredness
  • Swelling of salivary glands
  • Irritable, crying, unsettled and generally unhappy
  • Loss of appetite
  • Headache (usually observed in adolescents/adults)
  • Localised pain, redness and swelling at injection site
  • Occasionally injection site nodule, may last many weeks (no treatment needed)
  • Low-grade temperature (fever)

Pneumococcal vaccines (conjugate 7vPCV and polysaccharide 23vPPV)

Inactivated poliomyelitis vaccine (IPV) and IPV-containing vaccines

Rotavirus vaccine

Varicella vaccine (VV)

  • Localised pain, redness and swelling at injection site
  • Occasionally injection site nodule, may last many weeks (no treatment needed)
  • Low-grade temperature (fever)
  • Muscle aches
  • Localised pain, redness and swelling at injection site
  • Occasionally injection site nodule, may last many weeks (no treatment needed)
  • Low-grade temperature (fever)
  • Vomiting and diarrhoea can occur up to 7 days following vaccination
  • Localised pain, redness and swelling at injection site
  • Occasionally injection site nodule, may last many weeks (no treatment needed)
  • Temperature (fever, can be >39 0 C)

Seen 5–26 days after vaccination:

  • Pustular rash (2–5 lesions) usually at injection site, occasionally other parts of the body

Key to table

DTPa diphtheria-tetanus-pertussis acellular (infant/child formulation)
dTpa diphtheria-tetanus-pertussis acellular (adolescent/adult formulation)
HepA hepatitis A vaccine
HepB hepatitis B vaccine
Hib Haemophilus influenzae type b vaccine (PRP-OMP or PRP-T)
HPV human papillomavirus vaccine
Influenza influenza or flu vaccine
IPV inactivated poliomyelitis vaccine
MenCCV meningococcal C conjugate vaccine
MMR measles-mumps-rubella vaccine
7vPCV 7-valent pneumococcal conjugate vaccine
23vPPV 23-valent pneumococcal polysaccharide vaccine
Rotavirus rotavirus vaccine
VV varicella vaccine

What to do to manage injection site discomfort

Many vaccine injections may result in soreness, redness, itching, swelling or burning at the injection site for 1 to 2 days. Paracetamol might be required to ease the discomfort. Sometimes a small, hard lump may persist for some weeks or months. This should not be of concern and requires no treatment.

Managing fever after immunisation

Give extra fluids to drink. Do not overdress an infant if hot. Although the routine use of paracetamol at the time of vaccination is no longer necessary, it may be required if, for example, an infant or child has a high fever following vaccination. The dose of paracetamol is 15 mg/kg of paracetamol liquid, up to a maximum daily dose of 90 mg/kg per day.


Top of page

Help with accessing large documents

When accessing large documents (over 500 KB in size), it is recommended that the following procedure be used:

  1. Click the link with the RIGHT mouse button
  2. Choose "Save Target As.../Save Link As..." depending on your browser
  3. Select an appropriate folder on a local drive to place the downloaded file

Attempting to open large documents within the browser window (by left-clicking) may inhibit your ability to continue browsing while the document is opening and/or lead to system problems.

Help with accessing PDF documents

To view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. A number of PDF readers are available through the Australian Government Information Management Office (AGIMO) Web Guide website.